Crinetics Pharmaceuticals (CRNX) FCF Margin (2017 - 2026)
Crinetics Pharmaceuticals' quarterly FCF Margin came in at 1166.08% in Q1 2026, up 2340899.0% year-on-year from N/an in Q1 2025, and up 27.14% quarter-over-quarter from 1600.49% in Q4 2025.
Crinetics Pharmaceuticals has reported FCF Margin for 10 years, with the latest figure at 1166.08% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 2340899.0% year-over-year to 1166.08%; the trailing twelve-month figure through Mar 2026 stood at 2325.17% (up 3316562.0% YoY), and the FY2025 full-year result was 4985.5%, up 1753981.0% from the prior year.
- FCF Margin for Q1 2026 stood at 1166.08%, up from 1600.49% in the prior quarter.
- The five-year high for FCF Margin was 435.32% in Q1 2022, with the low at 74359.44% in Q3 2025.
- Average FCF Margin over 5 years is 12194.51%, with a median of 7387.05% recorded in 2022.
- Year-over-year, FCF Margin plunged 1629007 bps in 2025 and surged 2340899 bps in 2026.
- Tracing CRNX's FCF Margin over 5 years: stood at 5190.83% in 2022, then plunged by 150 bps to 12959.25% in 2023, then increased by 4 bps to 12471.93% in 2024, then jumped by 87 bps to 1600.49% in 2025, then increased by 27 bps to 1166.08% in 2026.
- The last three FCF Margin figures came in at 1166.08% (Q1 2026), 1600.49% (Q4 2025), and 74359.44% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn | -1,166.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,166.08% |
| Dec 31, 2025 | -1,600.49% |
| Sep 30, 2025 | -74,359.44% |
| Jun 30, 2025 | -8,732.10% |
| Mar 31, 2025 | -24,575.07% |
| Jun 30, 2024 | -12,471.93% |
| Mar 31, 2024 | -8,285.00% |
| Sep 30, 2023 | -12,959.25% |
| Jun 30, 2023 | -4,653.04% |
| Mar 31, 2023 | -1,520.49% |
| Dec 31, 2022 | -5,190.83% |
| Sep 30, 2022 | -8,261.79% |
| Jun 30, 2022 | -6,512.30% |
| Mar 31, 2022 | -435.32% |
| Dec 31, 2021 | -2,125.88% |
| Dec 31, 2020 | 22,471.83% |
| Mar 31, 2020 | -17,309.86% |
| Dec 31, 2019 | -4,079.44% |
| Sep 30, 2019 | -2,694.46% |
| Mar 31, 2019 | -1,952.86% |
| Dec 31, 2018 | -886.30% |
| Sep 30, 2018 | -1,056.02% |
| Jun 30, 2018 | -659.82% |
| Mar 31, 2018 | -785.97% |
| Dec 31, 2017 | -519.32% |
| Sep 30, 2017 | -384.53% |